- Home
- UNM vs ICLR Comparison
UNM vs ICLR Comparison
Compare UNM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNM
- ICLR
- Stock Information
- Founded
- UNM 1848
- ICLR 1990
- Country
- UNM United States
- ICLR Ireland
- Employees
- UNM N/A
- ICLR N/A
- Industry
- UNM Accident &Health Insurance
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- UNM Finance
- ICLR Health Care
- Exchange
- UNM Nasdaq
- ICLR Nasdaq
- Market Cap
- UNM 12.5B
- ICLR 11.4B
- IPO Year
- UNM 1986
- ICLR 1998
- Fundamental
- Price
- UNM $82.17
- ICLR $132.49
- Analyst Decision
- UNM Buy
- ICLR Buy
- Analyst Count
- UNM 13
- ICLR 12
- Target Price
- UNM $86.92
- ICLR $204.18
- AVG Volume (30 Days)
- UNM 1.2M
- ICLR 2.1M
- Earning Date
- UNM 04-29-2025
- ICLR 04-30-2025
- Dividend Yield
- UNM 2.05%
- ICLR N/A
- EPS Growth
- UNM 26.80
- ICLR 11.53
- EPS
- UNM 8.54
- ICLR 9.19
- Revenue
- UNM $12,778,600,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- UNM $4.43
- ICLR N/A
- Revenue Next Year
- UNM $3.95
- ICLR $2.61
- P/E Ratio
- UNM $9.61
- ICLR $14.22
- Revenue Growth
- UNM 1.82
- ICLR N/A
- 52 Week Low
- UNM $48.38
- ICLR $133.28
- 52 Week High
- UNM $84.48
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- UNM 60.40
- ICLR 35.20
- Support Level
- UNM $79.05
- ICLR $133.86
- Resistance Level
- UNM $82.36
- ICLR $141.21
- Average True Range (ATR)
- UNM 1.75
- ICLR 6.57
- MACD
- UNM 0.27
- ICLR 0.06
- Stochastic Oscillator
- UNM 96.88
- ICLR 8.05
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.